Laguno M - Search Results

1

Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study.

Martínez-Rebollar M, De La Mora L, Campistol M, Cabrera B, Bagué A, De Lazzari E, Torres B, González-Cordón A, Inciarte A, Ambrosioni J, Martínez E, Blanco JL, Forns X, Blanch J, Mallolas J, Laguno M. Martínez-Rebollar M, et al. Among authors: laguno m. Infect Dis Ther. 2021 Sep;10(3):1253-1266. doi: 10.1007/s40121-021-00448-0. Epub 2021 Apr 29. Infect Dis Ther. 2021. PMID: 33914265 Free PMC article.

2

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

Laguno M, Murillas J, Blanco JL, Martínez E, Miquel R, Sánchez-Tapias JM, Bargallo X, García-Criado A, de Lazzari E, Larrousse M, León A, Loncá M, Milinkovic A, Gatell JM, Mallolas J. Laguno M, et al. AIDS. 2004 Sep 3;18(13):F27-36. doi: 10.1097/00002030-200409030-00003. AIDS. 2004. PMID: 15316335 Clinical Trial.

3

Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study.

Biglia A, Blanco JL, Martínez E, Domingo P, Casamitjana R, Sambeat M, Milinkovic A, Garcia M, Laguno M, Leon A, Larrousse M, Lonca M, Mallolas J, Gatell JM. Biglia A, et al. Among authors: laguno m. Clin Infect Dis. 2004 Nov 15;39(10):1514-9. doi: 10.1086/425363. Epub 2004 Oct 25. Clin Infect Dis. 2004. PMID: 15546089

4

Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.

Laguno M, Blanch J, Murillas J, Blanco JL, León A, Lonca M, Larrousse M, Biglia A, Martinez E, García F, Miró JM, de Pablo J, Gatell JM, Mallolas J. Laguno M, et al. Antivir Ther. 2004 Dec;9(6):905-9. Antivir Ther. 2004. PMID: 15651749

5

Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine.

León A, Martinez E, Mallolas J, Laguno M, Blanco JL, Pumarola T, Gatell JM. León A, et al. Among authors: laguno m. AIDS. 2005 Jan 28;19(2):213-5. doi: 10.1097/00002030-200501280-00017. AIDS. 2005. PMID: 15668550

6

Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor.

Blanco JL, Biglia MA, Arnedo M, Martínez E, Mallolas J, Milinkovic A, Laguno M, Larrousse M, Leon A, Lonca M, García F, Miró JM, Pumarola T, Gatell JM. Blanco JL, et al. Among authors: laguno m. AIDS. 2005 May 20;19(8):829-31. doi: 10.1097/01.aids.0000168978.89961.22. AIDS. 2005. PMID: 15867498

7

High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir.

León A, Mallolas J, Martinez E, De Lazzari E, Pumarola T, Larrousse M, Milincovic A, Lonca M, Blanco JL, Laguno M, Biglia A, Gatell JM. León A, et al. Among authors: laguno m. AIDS. 2005 Oct 14;19(15):1695-7. doi: 10.1097/01.aids.0000186821.30489.16. AIDS. 2005. PMID: 16184042

8

Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutations.

Blanco JL, Biglia A, De Lazzari E, Mallolas J, Martinez E, Pumarola T, Larrousse M, Milinkovic A, León A, Lonca M, Laguno M, Gatell JM. Blanco JL, et al. Among authors: laguno m. AIDS. 2006 Sep 11;20(14):1891-2. doi: 10.1097/01.aids.0000244210.33876.26. AIDS. 2006. PMID: 16954732

9

Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin.

Laguno M, Larrousse M, Murillas J, Blanco JL, León A, Milinkovic A, Loncá M, Martinez E, Sánchez-Tapias JM, de Lazzari E, Gatell JM, Costa J, Mallolas J. Laguno M, et al. J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):174-8. doi: 10.1097/QAI.0b013e31802b812d. J Acquir Immune Defic Syndr. 2007. PMID: 17106276 Clinical Trial.

10

The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.

Milinkovic A, Martinez E, López S, de Lazzari E, Miró O, Vidal S, Blanco JL, Garrabou G, Laguno M, Arnaiz JA, Leon A, Larrousse M, Lonca M, Mallolas J, Gatell JM. Milinkovic A, et al. Among authors: laguno m. Antivir Ther. 2007;12(3):407-15. Antivir Ther. 2007. PMID: 17591031 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters